Samantha Semenkow
Stock Analyst at Citigroup
(1.82)
# 1,827
Out of 4,412 analysts
29
Total ratings
30.43%
Success rate
-4.78%
Average return
Main Sectors:
Top Industries:
15 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSVT 2seventy bio | Maintains: Buy | $9 → $12 | $4.26 | +182.02% | 2 | Apr 8, 2024 | |
| CABA Cabaletta Bio | Maintains: Buy | $26 → $30 | $11.01 | +172.48% | 2 | Apr 4, 2024 | |
| CPRX Catalyst Pharmaceuticals | Initiates: Buy | $27 | $14.89 | +81.33% | 1 | Mar 14, 2024 | |
| EDIT Editas Medicine | Maintains: Buy | $11 → $16 | $5.32 | +200.75% | 3 | Feb 29, 2024 | |
| LRMR Larimar Therapeutics | Maintains: Buy | $4.5 → $10 | $6.44 | +55.28% | 5 | Feb 13, 2024 | |
| SLRN Acelyrin | Initiates: Neutral | $8 | $4.24 | +88.68% | 1 | Dec 8, 2023 | |
| ALLO Allogene Therapeutics | Initiates: Buy | $7 | $2.89 | +142.21% | 1 | Dec 8, 2023 | |
| MLTX MoonLake Immunotherapeutics | Initiates: Buy | $72 | $42.49 | +69.45% | 1 | Dec 8, 2023 | |
| MORF Morphic Holding | Initiates: Buy | $46 | $28.07 | +63.88% | 1 | Dec 8, 2023 | |
| PRME Prime Medicine | Initiates: Neutral | $10 | $4.43 | +125.99% | 1 | Dec 8, 2023 | |
| ARGX argenx SE | Maintains: Buy | $610 → $591 | $372.80 | +58.53% | 3 | Nov 29, 2023 | |
| IMVT Immunovant | Maintains: Buy | $33 → $50 | $27.17 | +84.03% | 3 | Sep 27, 2023 | |
| SANA Sana Biotechnology | Initiates: Buy | $8 | $8.72 | -8.26% | 1 | Sep 5, 2023 | |
| BEAM Beam Therapeutics | Maintains: Buy | $60 → $56 | $21.38 | +161.93% | 3 | Aug 9, 2023 | |
| SNSE Sensei Biotherapeutics | Initiates: Buy | $6 | $1.02 | +488.24% | 1 | Dec 13, 2022 |
2seventy bio
Apr 8, 2024
Maintains: Buy
Price Target: $9 → $12
Current: $4.26
Upside: +182.02%
Cabaletta Bio
Apr 4, 2024
Maintains: Buy
Price Target: $26 → $30
Current: $11.01
Upside: +172.48%
Catalyst Pharmaceuticals
Mar 14, 2024
Initiates: Buy
Price Target: $27
Current: $14.89
Upside: +81.33%
Editas Medicine
Feb 29, 2024
Maintains: Buy
Price Target: $11 → $16
Current: $5.32
Upside: +200.75%
Larimar Therapeutics
Feb 13, 2024
Maintains: Buy
Price Target: $4.5 → $10
Current: $6.44
Upside: +55.28%
Acelyrin
Dec 8, 2023
Initiates: Neutral
Price Target: $8
Current: $4.24
Upside: +88.68%
Allogene Therapeutics
Dec 8, 2023
Initiates: Buy
Price Target: $7
Current: $2.89
Upside: +142.21%
MoonLake Immunotherapeutics
Dec 8, 2023
Initiates: Buy
Price Target: $72
Current: $42.49
Upside: +69.45%
Morphic Holding
Dec 8, 2023
Initiates: Buy
Price Target: $46
Current: $28.07
Upside: +63.88%
Prime Medicine
Dec 8, 2023
Initiates: Neutral
Price Target: $10
Current: $4.43
Upside: +125.99%
argenx SE
Nov 29, 2023
Maintains: Buy
Price Target: $610 → $591
Current: $372.80
Upside: +58.53%
Immunovant
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $27.17
Upside: +84.03%
Sana Biotechnology
Sep 5, 2023
Initiates: Buy
Price Target: $8
Current: $8.72
Upside: -8.26%
Beam Therapeutics
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $21.38
Upside: +161.93%
Sensei Biotherapeutics
Dec 13, 2022
Initiates: Buy
Price Target: $6
Current: $1.02
Upside: +488.24%